Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
A large subgroup of around 25% of schizophrenia patients suffers from obsessive-compulsive symptoms (OCS) and about 12% fulfill the diagnostic criteria of an obsessive-compulsive disorder (OCD). The additional occurrence of OCS is associated with high subjective burden of disease, additional neurocognitive impairment, poorer social and vocational functioning, greater service utilization and high levels of anxiety and depression. Comorbid patients can be assigned to heterogeneous subgroups. One hypothesis assumes that second generation antipsychotics (SGAs), most importantly clozapine, might aggravate or even induce second-onset OCS. Several arguments support this assumption, most importantly the observed chronological order of first psychotic manifestation, start of treatment with clozapine and onset of OCS. In addition, correlations between OCS-severity and dose and serum levels and duration of clozapine treatment hint toward a dose-dependent side effect. It has been hypothesized that genetic risk-factors dispose patients with schizophrenia to develop OCS. One study in a South Korean sample reported associations with polymorphisms in the gene SLC1A1 (solute carrier family 1A1) and SGA-induced OCS. However, this finding could not be replicated in European patients. Preliminary results also suggest an involvement of polymorphisms in the BDNF gene (brain-derived neurotrophic factor) and an interaction between markers of SLC1A1 and the gene DLGAP3 (disc large associated protein 3) as well as GRIN2B (N-methyl-D-aspartate receptor subunit 2B). Further research of well-defined samples, in particular studies investigating possible interactions of genetic risk-constellations and pharmacodynamic properties, are needed to clarify the assumed development of SGA-induced OCS. Results might improve pathogenic concepts and facilitate the definition of at risk populations, early detection and monitoring of OCS as well as multimodal therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524
The environment and schizophrenia
van Os, J., Kenis, G., & Rutten, B. P. F. (2010) · Nature · doi:10.1038/nature09563 · Cited by 1,572 · cited 2×
“These could include migration, other stressful life events, or effects of psychotropic substances (van Os and Kapur, 2009; van Os et al., 2008, 2010).”
BackgroundTiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Psychiatric Comorbidities and Schizophrenia
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn135 · Cited by 1,121 · cited 1×
“…have a high lifetime risk of about 25% for comorbid OCS and a recent meta-analysis reports that 12.1% also fulfill the criteria for an OCD (Figure 1C; Poyurovsky et al., 2004, 2012; Buckley et al., 2009; Lysaker and Whitney, 2009; Mukhopadhaya et al., 2009; Achim et al., 2011; Hadi et al., 2011).”
BackgroundInfluentialPractice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028 · cited 1×
“…and case series can hardly be reconciled with the fact, that CBT including exposure and response prevention is considered treatment of first choice for primary OCD with remarkably high effect sizes (Gava et al., 2007; Koran et al., 2007; Rosa-Alcazar et al., 2008; Kuelz and Voderholzer, 2011).”
Backgroundvan Os, J., Rutten, B. P., & Poulton, R. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn117 · Cited by 713
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635 · cited 1×
“Furthermore, antiobsessive effects of antipsychotics have also been reported in primary OCD, including OLZ, especially in cases with treatmentresistance to serotonergic antidepressants (Bloch et al., 2006; Bandelow et al., 2008; Dold et al., 2011; Muscatello et al., 2011).”
BackgroundFusar-Poli, P., Nelson, B., Valmaggia, L., Yung, A. R., & McGuire, P. K. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs136 · Cited by 589 · cited 3×
“Whereas higher impairment of psychosocial functioning (de Haan et al., 2012; DeVylder et al., 2012; Fusar-Poli et al., 2012; Hur et al., 2012) and more severe depressive symptoms (Niendam et al., 2009; DeVylder et al., 2012; Fontenelle et al., 2012; de Haan et al., 2013) have consistently been…”
BackgroundResultA meta-analysis of functional neuroimaging in obsessive-compulsive disorder
Whiteside, S. P., Port, J. D., & Abramowitz, J. S. (2004) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2004.07.001 · Cited by 520
How psychotherapy changes the brain – the contribution of functional neuroimaging
Linden, D. E. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001816 · Cited by 491
Cited by
Schizo-obsessive spectrum disorders: an update
Scotti-Muzzi, E., & Saide, O. L. (2017) · CNS Spectrums · doi:10.1017/s1092852916000390 · Cited by 65
Obsessive-compulsive symptoms in schizophrenia: an up-to-date review of literature
Tezenas du Montcel, C., Pelissolo, A., Schürhoff, F., & Pignon, B. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1051-y · Cited by 61
Jeon, S., Baek, J. H., Yang, S. Y., Choi, Y., Ahn, S. W., Ha, K., & Hong, K. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.012 · Cited by 34
Szmulewicz, A., Samamé, C., Caravotta, P., Martino, D. J., Igoa, A., Hidalgo-Mazzei, D., Colom, F., & Strejilevich, S. A. (2016) · International Journal of Bipolar Disorders · doi:10.1186/s40345-016-0047-3 · Cited by 28
Obsessive-Compulsive, Psychotic, and Autism Dimensions Overlap in Real World: A Case Report
Scala, M., Biondi, L., Serretti, A., & Fabbri, C. (2023) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000561 · Cited by 7
Metadata
- Authors
- Schirmbeck, F., & Zink, M.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 99-99
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2060233596
- Cited by
- 118
- References
- 30
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. https://app.cochat.ai/papers/10.3389/fphar.2013.00099
- The paper
- Schirmbeck, F., & Zink, M. (2013). Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2013.00099
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.